{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:16:45Z","timestamp":1792088205650,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Pharm Res"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/bf02969351","type":"journal-article","created":{"date-parts":[[2009,1,5]],"date-time":"2009-01-05T17:48:47Z","timestamp":1231177727000},"page":"637-647","source":"Crossref","is-referenced-by-count":17,"title":["Synthesis and anti-inflammatory testing of some new compounds incorporating 5-aminosalicylic acid (5-ASA) as potential prodrugs"],"prefix":"10.1007","volume":"28","author":[{"given":"Abdel-Alim Mohamed","family":"Abdel-Alim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Nasser Ahmed","family":"El-Shorbagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia Galal","family":"Abdel-Moty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajjaj Hassan Mohamed","family":"Abdel-Allah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"H.7","key":"BF02969351_CR1","first-page":"394","volume":"35","author":"A. M. Abdel-Alim","year":"1980","unstructured":"Abdel-Alim, A. M., Abdel-Kader, M. A., and El-Kossi, A. A., Synthesis and anti-inflammatory activity of certain newN, N\u2032-Oxamides.Pharmazie, 35(H.7), 394\u2013398 (1980).","journal-title":"Pharmazie"},{"key":"BF02969351_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(93)90121-U","volume":"97","author":"M. Abu Shamate","year":"1993","unstructured":"Abu Shamate M., The role of the gastrointestinal microflora in the metabolism of drugs.Int. J. Pharm., 97, 1\u201313 (1993).","journal-title":"Int. J. Pharm."},{"key":"BF02969351_CR3","first-page":"194","volume-title":"Handbook of Microbiological Media","author":"R. M. Atlas","year":"1996","unstructured":"Atlas, R. M., \u201cHandbook of Microbiological Media\u201d, 2nd ed., Lawrence C. Parks editor, 1996, CRC press, New York, pp. 194, 99, 363.","edition":"2nd ed."},{"key":"BF02969351_CR4","first-page":"49","volume-title":"Collective Volume I","author":"J. B. Conant","year":"1941","unstructured":"Conant J. B., Lutz R.F., and Corson B.B., \u201cOrganic Synthesis\u201d, 2d edn., Ed. By Blatt, A. H. and Gilman, H.; Collective Volume I (1941), John Wiley and Sons, Inc., New York, pp. 49\u201351.","edition":"2d edn."},{"issue":"3","key":"BF02969351_CR5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jps.2600740304","volume":"74","author":"N. Bodor","year":"1985","unstructured":"Bodor, N. and Abdel Alim, A. M., Improved delivery through biological membranes. XIX: novel redox carriers for brain-specific chemical delivery systems.J. Pharm. Sci., 74(3), 241\u2013245 (1985).","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"BF02969351_CR6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jps.2600730324","volume":"73","author":"N. Bodor","year":"1984","unstructured":"Bodor, N. and Farag, H. H., Improved delivery through biological membranes. XIV: brain-specific, sustained delivery of testosterone using a redox chemical delivery system.J. Pharm. Sci., 73(3), 385\u2013389 (1984).","journal-title":"J. Pharm. Sci."},{"key":"BF02969351_CR7","first-page":"751","volume-title":"Foye's Principles of Medicinal Chemistry","author":"R. F. Borne","year":"2002","unstructured":"Borne, R. F., \u201cNonsteroidal Anti-inflammatory Drugs\u201d, In \u201cFoye's Principles of Medicinal Chemistry\u201d, 5th ed., (T. L. Lemke, and D. A. Williams; eds) 2002, Alea and Febiger, Philadelphia, pp. 751\u2013793.","edition":"5th ed."},{"key":"BF02969351_CR8","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1021\/jm00363a015","volume":"26","author":"J. P. Brown","year":"1983","unstructured":"Brown, J. P., McGarraugh, G. V., Parkinson, T. M., Wingard R. E., and Onderdonk, B., A polymeric drug for treatment of inflammatory bowel disease.J. Med. Chem., 26, 1300\u20131307 (1983).","journal-title":"J. Med. Chem."},{"issue":"7","key":"BF02969351_CR9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF01299921","volume":"28","author":"R. P. Chan","year":"1983","unstructured":"Chan, R. P., Pope, D. J., Gilbert, A. P., and Sacra, P. J., Baron, J. H., and Lennard-Jones J. E., Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide.Dig. Dis. Sci., 28(7), 609\u2013615 (1983).","journal-title":"Dig. Dis. Sci."},{"key":"BF02969351_CR10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.2042-7158.1957.tb12347.x","volume":"9","author":"L. V. Coates","year":"1957","unstructured":"Coates, L. V., Drain, D. L., Kerridge, K. A., Macrae, F. J., and Tattersal, K., Preparation and antifungal activity of some salicylic acid derivatives.J. Pharm. Pharmacol., 9, 855\u2013862 (1957); through Chem. Abstr. 52, 8087h (1958).","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"BF02969351_CR11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0168-3659(98)00167-9","volume":"58","author":"S. Davaran","year":"1999","unstructured":"Davaran, S., Hanee, J., and Khosravi, A., Release of 5-aminosalicylic acid from acrylic type polymeric prodrugs designed for colon-specific drug delivery.J. Controlled Release, 58(3), 279\u2013287 (1999); through Chem. Abstr., 131, 63362p (1999).","journal-title":"J. Controlled Release"},{"key":"BF02969351_CR12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1211\/0022357011778043","volume":"53","author":"J. C. Duffy","year":"2001","unstructured":"Duffy, J. C., Dearden, J. C., and Rostron, C., Design, synthesis and biological testing of a novel series of anti-inflammatory drugs.J. Pharm. Pharmacol. 53, 1505\u2013514 (2001).","journal-title":"J. Pharm. Pharmacol."},{"key":"BF02969351_CR13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-3565(25)05180-8","volume":"107","author":"N. B. Eddy","year":"1953","unstructured":"Eddy, N. B. and Leimback, D., Synthetic analgesics II. Dithienylbutenyl and dithienybutylamines.J. Pharmacol. Exp. Ther., 107, 385\u2013393 (1953).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02969351_CR14","first-page":"952","volume-title":"Vogel's Textbook of Practical Organic Chemistry","year":"1989","unstructured":"Furniss, B. S., Hannaford, A. J., Smith, P. W. G., and Tatchell, A. R. (eds.), \u201cVogel's Textbook of Practical Organic Chemistry\u201d 5th edn., (1989), EIBS with Longman, U.K., p. 952.","edition":"5th edn."},{"key":"BF02969351_CR15","unstructured":"Hans, K. and Josef, K., Novel salicylic acid salt. DE 3340028 (1985-05-15)."},{"key":"BF02969351_CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(81)90502-X","volume":"2","author":"J. R. S. Hoult","year":"1981","unstructured":"Hoult, J. R. S. and Dage, H., 5-Aminosalicylic acid, a co-factor for colonic prostacyclin synthesis?The Lancet, 2, 255 (1981).","journal-title":"The Lancet"},{"key":"BF02969351_CR17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3891\/acta.chem.scand.03-0205","volume":"3","author":"K. A. Jensen","year":"1949","unstructured":"Jensen, K. A. and Linholt, S. C., Some substituted amides of salicylic acid.Acta Chemica Scand., 3, 205\u2013206 (1949).","journal-title":"Acta Chemica Scand."},{"key":"BF02969351_CR18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1021\/jm00209a002","volume":"21","author":"H. Jones","year":"1978","unstructured":"Jones, H., Fordice, M. W., Greenwald, R. B., Hannah, J., Jacobs, A., Ruyle, W. V., Walford, G. L., and Shen, T. Y., Synthesis and analgesic-antiinflammatory activity of some 4- and 5-substituted heteroarylsalicylic acids.J. Med. Chem., 21, 1100\u20131104 (1978).","journal-title":"J. Med. Chem."},{"key":"BF02969351_CR19","unstructured":"Jorgensen, A. P., Hvidovre and Torkil M., Benzoic acid derivatives and use thereof.US Pat. Appl. No., U.S. 4, 933, 330 (1990)."},{"key":"BF02969351_CR20","unstructured":"Jorgensen, A. P. and Monne T., Aminosalicylic acid derivatives for the treatment of psoriasis, Eur. Pat. Appl. No., EP 291, 159 (1988); through Chem. Abstr., 111, 102720n (1989)."},{"issue":"5","key":"BF02969351_CR21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/(SICI)1520-6017(200005)89:5<594::AID-JPS5>3.0.CO;2-8","volume":"89","author":"Y. J. Jung","year":"2000","unstructured":"Jung, Y. J., Lee, J. S., and Kim, Y. M., Synthesis andin vitro\/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid.J. Pharm. Sci., 89(5), 594\u2013602 (2000).","journal-title":"J. Pharm. Sci."},{"key":"BF02969351_CR22","unstructured":"Margaretha, O. and Franciscus, H. R., Use of 5-aminosalicylic acid in the treatment of dermatological disordes.Eur. Pat. Appl. No., EP 0352826 (1990)."},{"key":"BF02969351_CR23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0223-5234(89)90048-2","volume":"24","author":"N. L. Moller","year":"1989","unstructured":"Moller, N. L., Diet Zel, K. E., Schneider, H. T., and Brune, K., Novel 5-aminosalicylic acid NSAID conjugates: synthesis; pharmacological and toxicological properties.Eur. J. Med. Chem., 24, 463\u2013469 (1989).","journal-title":"Eur. J. Med. Chem."},{"key":"BF02969351_CR24","unstructured":"Orlikovs, G., Medicine for the treatment of rheumatoid arthritis and similar diseases.Latv. Pat. Appl. No., LV 12, 370, 20, 2000; through Chem. Abstr., 134, 173026b (2001)."},{"issue":"8","key":"BF02969351_CR25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/A:1015930220855","volume":"6","author":"M. J. Phelan","year":"1989","unstructured":"Phelan, M. J. and Bodor, N., Improved delivery through biological membranes. XXXVII. synthesis and stability of novel redox derivatives of naproxen and indomethacin.Pharm. Res., 6(8), 667\u2013676 (1989).","journal-title":"Pharm. Res."},{"key":"BF02969351_CR26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3565(25)29238-2","volume":"181","author":"M. A. Peppercorn","year":"1972","unstructured":"Peppercorn, M. A. and Goldman, P., The role of intestinal bacteria in the metabolism of salicylazosulfapyridine.J. Pharmacol. Exp. Ther., 181, 555\u2013562 (1972).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02969351_CR27","unstructured":"Rokos, H., Konczak, H., and Forth, W., 5-Aminosalicylic acid-O-sulfates of physiologically acceptable bases, process for the preparation thereof and drugs containing same.US Pat. Appl. No., US 4, 837, 229 (1989)."},{"key":"BF02969351_CR28","unstructured":"Shen, T. Y., Walford, G. L., Witzel, B. E., and Jones, H., Treatment of inflammation.US Pat. Appl. No., US 3, 632, 760 (1972)."},{"key":"BF02969351_CR29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ardp.19843170707","volume":"317","author":"I. P. Singh","year":"1984","unstructured":"Singh, I. P., Gurtu, S., Kumar, A., Sinha, J. N., Bhargava, P., and Shanker, K., Anti-inflammatory activities of compounds derived from salicylic and benzoic acids.Arch. Pharm. (weinheim, Ger.), 317, 609\u2013614 (1984).","journal-title":"Arch. Pharm. (weinheim, Ger.)"},{"key":"BF02969351_CR30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1521-4184(19999)332:9<321::AID-ARDP321>3.0.CO;2-A","volume":"332","author":"F. Sztaricskai","year":"1999","unstructured":"Sztaricskai, F., Takacs, I. E., Pusztai, F., Szabo, G., and Csipo I., Antiulcer effect of theN- andO-\u03b2-d-glucopyranosides of 5-aminosalicylic acid.Arch. Pharm. Pharm. Med. Chem., 332, 321\u2013326 (1999).","journal-title":"Arch. Pharm. Pharm. Med. Chem."},{"issue":"3","key":"BF02969351_CR31","first-page":"714","volume":"27","author":"G. T. D. Thomson","year":"2000","unstructured":"Thomson, G. T. D., Thomson, B. R. J., Thomson, K. S., Ducharne, J. S., and Ducharne J. S., Clinical efficacy of mesalamine in the treatment of the spondyloarthropathies.J. Rheumatol., 27(3) 714 (2000); throughChem. Abstr., 132, 231684m (2000).","journal-title":"J. Rheumatol."},{"key":"BF02969351_CR32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0378-5173(84)90128-5","volume":"19","author":"J. Truelove","year":"1984","unstructured":"Truelove, J., Bawarshi-Nassar, R., Chen, N. R., and Hassain, A., Solubility enhancement of some developmental anticancer nucloside analogs by complexation with nicotinamide.Int. J. Pharm., 19, 17\u201325 (1984).","journal-title":"Int. J. Pharm."},{"key":"BF02969351_CR33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0022-3565(25)05239-5","volume":"108","author":"E. L. Way","year":"1953","unstructured":"Way, E. L., Takemori, A. E., Smith, G. E., Anderson, H. H., and Brodie, D. C., The toxicity and analgetic activity of some congeners of salicylamide.J. Pharm. Exp. Ther., 108, 450\u2013460 (1953).","journal-title":"J. Pharm. Exp. Ther."},{"key":"BF02969351_CR34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/gut.23.12.1081","volume":"23","author":"C. P. Willoughby","year":"1982","unstructured":"Willoughby, C. P., Aronson, J. R., Agback, H., Bodin, N. O., and Truelove, S. C., Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.Gut, 23, 1081\u20131087 (1982).","journal-title":"Gut"},{"key":"BF02969351_CR35","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","volume":"111","author":"C. A. Winter","year":"1962","unstructured":"Winter, C. A., Risley, E. A., and Nuss, G. W., Carrageenin-induced oedema in the hind paw of rat as an assay for anti-inflammatory activity.Proc. Soc. Exp. Biol. Ther., 111, 544\u2013547 (1962).","journal-title":"Proc. Soc. Exp. Biol. Ther."}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02969351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02969351\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02969351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T19:31:46Z","timestamp":1738870306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02969351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["BF02969351"],"URL":"https:\/\/doi.org\/10.1007\/bf02969351","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}